Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Anesthesia Depth During Opioid Free Anesthesia
Region Halland
Prosocial Effects of MDMA
University of Chicago
Microdosing Psychedelics to Improve Mood
Rotem Petranker
A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Bristol-Myers Squibb
Brain Network Dynamics of Depression During Esketamine Treatment
University of North Carolina, Chapel Hill
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Centre for Addiction and Mental Health
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Psilocybin-assisted CBT for Depression
University of California, Los Angeles
The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery
Tiva Group
A Trial of GH001 in Patients With Treatment-resistant Depression
GH Research Ireland Limited
Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions
University Hospital, Basel, Switzerland
Opioid-free Analgesia in Intensive Care Unit
Centre Hospitalier Universitaire de Nīmes
Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects
Reconnect Labs
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
Medical University of South Carolina
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
Medical University of Gdansk
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
University of Nebraska
Effect of Ketamine Infusion on BIS Values
University of Padova
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies
Beth Israel Deaconess Medical Center
Mindfulness and Psychedelics
Milan Scheidegger
Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis
Novartis
The Effects of Sedatives on Tobacco Use Disorder Version 2
Wake Forest University Health Sciences
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD
COMPASS Pathways
The 'Wearing Off' Effect of DMT
Novartis Pharmaceuticals
IM and IV SPL026 Drug Product in Healthy Participants
Small Pharma Ltd
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
University of Utah
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
Usona Institute
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
GH Research Ireland Limited
SPL026 With or Without SSRIs in Participants With MDD
Small Pharma Ltd
Psilocybin in Adults With and Without Autism Spectrum Disorder
King's College London
Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects
Summa Health System
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Theresa Jacob, PhD, MPH
Nociception Level During Opioid-sparing Anaesthesia Versus Conventional Opioid-based Anaesthesia
University Hospital, Basel, Switzerland
Acute Dose-dependent Effects of DMT in Healthy Subjects
University Hospital, Basel, Switzerland
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Emory University
PsilOCD: A Pharmacological-Challenge Feasibility Study
Imperial College London
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
COMPASS Pathways
Psilocybin-assisted Therapy for Phantom Limb Pain
University of California, San Diego
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
University of Texas Southwestern Medical Center
Acute Effects of R- and S-MDMA in Healthy Subjects
University Hospital, Basel, Switzerland
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
Cessatech A/S
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Madeline Fields
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Definium Therapeutics US, Inc.
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
Joshua Rosenblat
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Albany Research Institute, Inc.
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Assistance Publique Hopitaux De Marseille
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.